CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 186 filers reported holding CYTOKINETICS INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,972,455 | -17.8% | 100,898 | -9.0% | 0.01% | 0.0% |
| Q2 2023 | $3,617,199 | -6.1% | 110,889 | +1.2% | 0.01% | -16.7% |
| Q1 2023 | $3,854,114 | -24.0% | 109,523 | -1.0% | 0.01% | -25.0% |
| Q4 2022 | $5,068,333 | +2.1% | 110,614 | +8.0% | 0.01% | 0.0% |
| Q3 2022 | $4,963,000 | +22.5% | 102,438 | -0.6% | 0.01% | +33.3% |
| Q2 2022 | $4,050,000 | +11.8% | 103,089 | +4.7% | 0.01% | +20.0% |
| Q1 2022 | $3,624,000 | -25.5% | 98,455 | -7.7% | 0.01% | -16.7% |
| Q4 2021 | $4,864,000 | +31.8% | 106,724 | +3.3% | 0.01% | +20.0% |
| Q3 2021 | $3,691,000 | +98.7% | 103,281 | +10.0% | 0.01% | +150.0% |
| Q2 2021 | $1,858,000 | -20.2% | 93,911 | -6.1% | 0.00% | -33.3% |
| Q1 2021 | $2,327,000 | +11.5% | 100,063 | -0.4% | 0.00% | 0.0% |
| Q4 2020 | $2,087,000 | -4.0% | 100,446 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,175,000 | +8.8% | 100,446 | +18.5% | 0.00% | -25.0% |
| Q2 2020 | $1,999,000 | +101.7% | 84,800 | +0.9% | 0.00% | +100.0% |
| Q1 2020 | $991,000 | +7.7% | 84,084 | -3.1% | 0.00% | 0.0% |
| Q4 2019 | $920,000 | -6.8% | 86,751 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $987,000 | +4.0% | 86,751 | +2.9% | 0.00% | 0.0% |
| Q2 2019 | $949,000 | +65.3% | 84,316 | +18.9% | 0.00% | +100.0% |
| Q1 2019 | $574,000 | +15.7% | 70,914 | -9.6% | 0.00% | 0.0% |
| Q4 2018 | $496,000 | -28.9% | 78,484 | +10.8% | 0.00% | 0.0% |
| Q3 2018 | $698,000 | +19.5% | 70,832 | +0.7% | 0.00% | 0.0% |
| Q2 2018 | $584,000 | +26.4% | 70,367 | +9.6% | 0.00% | 0.0% |
| Q1 2018 | $462,000 | -13.5% | 64,210 | -2.0% | 0.00% | 0.0% |
| Q4 2017 | $534,000 | -44.6% | 65,489 | -1.5% | 0.00% | -50.0% |
| Q3 2017 | $964,000 | +8.2% | 66,456 | -9.7% | 0.00% | 0.0% |
| Q2 2017 | $891,000 | +4.0% | 73,608 | +10.3% | 0.00% | 0.0% |
| Q1 2017 | $857,000 | +1.1% | 66,708 | -4.4% | 0.00% | 0.0% |
| Q4 2016 | $848,000 | +29.3% | 69,808 | -2.4% | 0.00% | +100.0% |
| Q3 2016 | $656,000 | -2.7% | 71,508 | +0.7% | 0.00% | 0.0% |
| Q2 2016 | $674,000 | +30.1% | 71,008 | -3.4% | 0.00% | 0.0% |
| Q1 2016 | $518,000 | -22.9% | 73,475 | +14.3% | 0.00% | -50.0% |
| Q4 2015 | $672,000 | +58.9% | 64,286 | +1.7% | 0.00% | +100.0% |
| Q3 2015 | $423,000 | -0.5% | 63,186 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $425,000 | -0.2% | 63,186 | +0.5% | 0.00% | 0.0% |
| Q1 2015 | $426,000 | -16.6% | 62,898 | -1.4% | 0.00% | 0.0% |
| Q4 2014 | $511,000 | +128.1% | 63,798 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $224,000 | -25.8% | 63,525 | +0.6% | 0.00% | 0.0% |
| Q2 2014 | $302,000 | -46.6% | 63,162 | +6.0% | 0.00% | 0.0% |
| Q1 2014 | $566,000 | +81.4% | 59,562 | +23.9% | 0.00% | 0.0% |
| Q4 2013 | $312,000 | -13.8% | 48,062 | +0.8% | 0.00% | 0.0% |
| Q3 2013 | $362,000 | -27.5% | 47,662 | +10.4% | 0.00% | -50.0% |
| Q2 2013 | $499,000 | – | 43,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,106,989 | $14,159,000 | 2.50% |
| Healthcare Value Capital, LLC | 100,000 | $672,000 | 0.71% |
| First Light Asset Management, LLC | 218,792 | $1,470,000 | 0.69% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 435,202 | $2,925,000 | 0.67% |
| TFS CAPITAL LLC | 899,951 | $6,048,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,250 | $2,838,000 | 0.28% |
| ALGERT GLOBAL LLC | 73,181 | $492,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $15,603,000 | 0.13% |
| Leisure Capital Management | 17,567 | $118,000 | 0.12% |
| Rotella Capital Management, Inc. | 15,778 | $106,000 | 0.09% |